Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 + T cells 1 , 2 , 3 . HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 432; no. 7018; pp. 769 - 775
Main Authors Kiepiela, Photini, Leslie, Alasdair J., Honeyborne, Isobella, Ramduth, Danni, Thobakgale, Christina, Chetty, Senica, Rathnavalu, Prinisha, Moore, Corey, Pfafferott, Katja J., Hilton, Louise, Zimbwa, Peter, Moore, Sarah, Allen, Todd, Brander, Christian, Addo, Marylyn M., Altfeld, Marcus, James, Ian, Mallal, Simon, Bunce, Michael, Barber, Linda D., Szinger, James, Day, Cheryl, Klenerman, Paul, Mullins, James, Korber, Bette, Coovadia, Hoosen M., Walker, Bruce D., Goulder, Philip J. R.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 09.12.2004
Nature Publishing
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 + T cells 1 , 2 , 3 . HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8 + T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8 + T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8 + T-cell activity 4 , 5 . In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8 + T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression ( P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles 6 , 7 , 8 . The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
AbstractList The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 super(+) T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8 super(+) T cells. However, the relative contributions of HLA-A and-B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8 super(+) T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8 super(+) T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8 super(+) T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 + T cells 1 , 2 , 3 . HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8 + T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8 + T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8 + T-cell activity 4 , 5 . In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8 + T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression ( P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles 6 , 7 , 8 . The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. [PUBLICATION ABSTRACT]
Audience Academic
Author Goulder, Philip J. R.
Honeyborne, Isobella
Chetty, Senica
Allen, Todd
James, Ian
Coovadia, Hoosen M.
Brander, Christian
Thobakgale, Christina
Korber, Bette
Walker, Bruce D.
Klenerman, Paul
Day, Cheryl
Moore, Corey
Ramduth, Danni
Zimbwa, Peter
Rathnavalu, Prinisha
Kiepiela, Photini
Addo, Marylyn M.
Hilton, Louise
Mullins, James
Mallal, Simon
Szinger, James
Leslie, Alasdair J.
Moore, Sarah
Altfeld, Marcus
Barber, Linda D.
Pfafferott, Katja J.
Bunce, Michael
Author_xml – sequence: 1
  givenname: Photini
  surname: Kiepiela
  fullname: Kiepiela, Photini
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 2
  givenname: Alasdair J.
  surname: Leslie
  fullname: Leslie, Alasdair J.
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 3
  givenname: Isobella
  surname: Honeyborne
  fullname: Honeyborne, Isobella
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 4
  givenname: Danni
  surname: Ramduth
  fullname: Ramduth, Danni
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 5
  givenname: Christina
  surname: Thobakgale
  fullname: Thobakgale, Christina
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 6
  givenname: Senica
  surname: Chetty
  fullname: Chetty, Senica
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 7
  givenname: Prinisha
  surname: Rathnavalu
  fullname: Rathnavalu, Prinisha
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 8
  givenname: Corey
  surname: Moore
  fullname: Moore, Corey
  organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital
– sequence: 9
  givenname: Katja J.
  surname: Pfafferott
  fullname: Pfafferott, Katja J.
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 10
  givenname: Louise
  surname: Hilton
  fullname: Hilton, Louise
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 11
  givenname: Peter
  surname: Zimbwa
  fullname: Zimbwa, Peter
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 12
  givenname: Sarah
  surname: Moore
  fullname: Moore, Sarah
  organization: Department of Microbiology, University of Washington
– sequence: 13
  givenname: Todd
  surname: Allen
  fullname: Allen, Todd
  organization: Partners AIDS Research Center, Massachusetts General Hospital
– sequence: 14
  givenname: Christian
  surname: Brander
  fullname: Brander, Christian
  organization: Partners AIDS Research Center, Massachusetts General Hospital
– sequence: 15
  givenname: Marylyn M.
  surname: Addo
  fullname: Addo, Marylyn M.
  organization: Partners AIDS Research Center, Massachusetts General Hospital
– sequence: 16
  givenname: Marcus
  surname: Altfeld
  fullname: Altfeld, Marcus
  organization: Partners AIDS Research Center, Massachusetts General Hospital
– sequence: 17
  givenname: Ian
  surname: James
  fullname: James, Ian
  organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital
– sequence: 18
  givenname: Simon
  surname: Mallal
  fullname: Mallal, Simon
  organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital
– sequence: 19
  givenname: Michael
  surname: Bunce
  fullname: Bunce, Michael
  organization: Dynal Biotech Ltd
– sequence: 20
  givenname: Linda D.
  surname: Barber
  fullname: Barber, Linda D.
  organization: Anthony Nolan Research Institute, Royal Free Hospital
– sequence: 21
  givenname: James
  surname: Szinger
  fullname: Szinger, James
  organization: Santa Fe Institute, Los Alamos National Laboratory
– sequence: 22
  givenname: Cheryl
  surname: Day
  fullname: Day, Cheryl
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 23
  givenname: Paul
  surname: Klenerman
  fullname: Klenerman, Paul
  organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research
– sequence: 24
  givenname: James
  surname: Mullins
  fullname: Mullins, James
  organization: Department of Microbiology, University of Washington
– sequence: 25
  givenname: Bette
  surname: Korber
  fullname: Korber, Bette
  organization: Santa Fe Institute, Los Alamos National Laboratory
– sequence: 26
  givenname: Hoosen M.
  surname: Coovadia
  fullname: Coovadia, Hoosen M.
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal
– sequence: 27
  givenname: Bruce D.
  surname: Walker
  fullname: Walker, Bruce D.
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Partners AIDS Research Center, Massachusetts General Hospital, Howard Hughes Medical Institute
– sequence: 28
  givenname: Philip J. R.
  surname: Goulder
  fullname: Goulder, Philip J. R.
  email: philip.goulder@ndm.ox.ac.uk
  organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, Partners AIDS Research Center, Massachusetts General Hospital
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16328802$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15592417$$D View this record in MEDLINE/PubMed
BookMark eNqF0l1v0zAUBuAIDbFucMU9ipAGQpDhr9jOZSkfm1SBNAZcRq5zXDyldmc7CP49Li3qOnXgXFiynvNaOT5HxYHzDoriMUanGFH52qk0BEAUY3qvGGEmeMW4FAfFCCEiKyQpPyyOYrxCCNVYsAfFIa7rhjAsRsXFW7-wTrlUWmf6AZyG0pvybDqu3uSjcgGdVcm6eZm-Q7n0CVyyqi-1r-CH74dkvftTcP61VK5bFT4s7hvVR3i02Y-LL-_fXU7OqumnD-eT8bTSXLJUNZyBZKrptGJAZGNmXadI3aGGzggHg5ikTNMaCc6EVsgoY3BGRFLTcETpcfF8nbsM_nqAmNqFjRr6XjnwQ2wFo5iLhq3ks39KLrBkNeX_hVjwpiGYZfj0FrzyQ3D5d1uCWJ1XgzOq1miuemhzf30KSs_BQVB9fkNj8_EYS04kp0RsQ3e8Xtrr9iY63YPy18HC6r2pL3YKsknwM83VEGN7_vli1768244vv00-7uonmyYMszwn7TLYhQq_2r_TlcHJBqioVW-CctrGrcspUiKyvVYHH2MAsyWoXc14e2PGs8a3tLZJrQYxd8L2d9S8WtfEnOzmELbvtY__BrUXB_M
CODEN NATUAS
CitedBy_id crossref_primary_10_1093_infdis_jiw093
crossref_primary_10_1586_erv_10_106
crossref_primary_10_1128_JVI_01547_06
crossref_primary_10_1128_JVI_00932_09
crossref_primary_10_1258_jrsm_2009_090183
crossref_primary_10_1371_journal_pone_0030302
crossref_primary_10_1016_j_medj_2024_06_008
crossref_primary_10_1016_j_vaccine_2007_08_020
crossref_primary_10_1128_JVI_01535_21
crossref_primary_10_1089_aid_2012_0160
crossref_primary_10_1371_journal_pone_0040100
crossref_primary_10_1089_aid_2007_0024
crossref_primary_10_1128_JVI_01879_10
crossref_primary_10_1002_eji_200940079
crossref_primary_10_1128_JVI_01020_12
crossref_primary_10_1097_QAD_0000000000000284
crossref_primary_10_1128_JVI_01960_19
crossref_primary_10_1038_s41467_018_07209_7
crossref_primary_10_1097_QAD_0b013e328045c4bd
crossref_primary_10_1186_1743_422X_5_141
crossref_primary_10_1136_amiajnl_2012_000867
crossref_primary_10_1128_JVI_02082_16
crossref_primary_10_1038_emi_2012_26
crossref_primary_10_1111_tan_15298
crossref_primary_10_1073_pnas_0500649102
crossref_primary_10_1097_QAI_0b013e3182036f14
crossref_primary_10_1128_JVI_01754_06
crossref_primary_10_1186_1742_4690_10_72
crossref_primary_10_1097_QAD_0000000000001382
crossref_primary_10_1097_QAD_0b013e3282f470e4
crossref_primary_10_1016_j_vaccine_2012_05_049
crossref_primary_10_1128_JVI_02483_09
crossref_primary_10_4049_jimmunol_1302667
crossref_primary_10_1038_icb_2011_34
crossref_primary_10_1089_aid_2016_0168
crossref_primary_10_1002_hep_21889
crossref_primary_10_1007_s11904_006_0003_4
crossref_primary_10_1016_j_virol_2010_06_002
crossref_primary_10_1182_blood_2006_06_030668
crossref_primary_10_1089_aid_2007_0124
crossref_primary_10_1371_journal_pone_0041696
crossref_primary_10_1371_journal_pcbi_1002381
crossref_primary_10_1128_CVI_00015_13
crossref_primary_10_1016_j_jim_2008_11_003
crossref_primary_10_1002_eji_200940295
crossref_primary_10_1038_ng_486
crossref_primary_10_1371_journal_pone_0054300
crossref_primary_10_2217_17469600_1_4_399
crossref_primary_10_1007_s00251_019_01148_3
crossref_primary_10_1128_JVI_02689_06
crossref_primary_10_1128_jvi_01248_22
crossref_primary_10_1038_s41586_023_06370_4
crossref_primary_10_1128_JVI_01409_17
crossref_primary_10_1038_s41467_019_10724_w
crossref_primary_10_1371_journal_pbio_1001208
crossref_primary_10_1128_JVI_01480_18
crossref_primary_10_1038_s41576_021_00378_0
crossref_primary_10_1371_journal_pone_0010900
crossref_primary_10_1097_QAD_0b013e3280123840
crossref_primary_10_1089_aid_2012_0171
crossref_primary_10_1177_135965350801300218
crossref_primary_10_1186_1471_2334_9_201
crossref_primary_10_1186_s12977_021_00554_4
crossref_primary_10_1016_j_humimm_2009_08_012
crossref_primary_10_1097_COH_0000000000000541
crossref_primary_10_4049_jimmunol_175_1_367
crossref_primary_10_1038_ng2035
crossref_primary_10_1126_science_aao4572
crossref_primary_10_1007_s11908_007_0012_5
crossref_primary_10_1128_JVI_02084_07
crossref_primary_10_1007_s00439_014_1465_x
crossref_primary_10_2217_fvl_11_134
crossref_primary_10_1128_JVI_00624_07
crossref_primary_10_1128_JVI_02607_07
crossref_primary_10_1002_eji_200737365
crossref_primary_10_1097_COH_0000000000000751
crossref_primary_10_1093_infdis_jiz294
crossref_primary_10_4049_jimmunol_1103472
crossref_primary_10_3389_fimmu_2021_669241
crossref_primary_10_1038_nature07746
crossref_primary_10_1038_s41467_019_08311_0
crossref_primary_10_1089_aid_2021_0055
crossref_primary_10_1177_135965350801300508
crossref_primary_10_1128_JVI_80_4_1637_1644_2006
crossref_primary_10_4049_jimmunol_1401017
crossref_primary_10_1126_science_1123016
crossref_primary_10_1038_nri3277
crossref_primary_10_1128_JVI_00804_11
crossref_primary_10_1093_nar_gkv1198
crossref_primary_10_1128_JVI_02276_10
crossref_primary_10_1126_scitranslmed_3003984
crossref_primary_10_4049_jimmunol_1001561
crossref_primary_10_1128_JVI_03464_14
crossref_primary_10_4049_jimmunol_0903227
crossref_primary_10_1038_nm_4100
crossref_primary_10_1371_journal_ppat_1007110
crossref_primary_10_1128_jvi_00954_23
crossref_primary_10_1097_QAD_0b013e3280b07b5b
crossref_primary_10_1089_aid_2015_0313
crossref_primary_10_1016_j_bjid_2018_12_002
crossref_primary_10_1128_JVI_03303_13
crossref_primary_10_1128_JVI_00575_06
crossref_primary_10_1007_s00251_017_1010_x
crossref_primary_10_1128_JVI_02634_13
crossref_primary_10_1007_s00281_014_0447_3
crossref_primary_10_1016_j_virol_2009_10_002
crossref_primary_10_1093_infdis_jiq122
crossref_primary_10_1128_JVI_01144_10
crossref_primary_10_1093_infdis_jiq125
crossref_primary_10_2174_1570162X17666191017105910
crossref_primary_10_4049_jimmunol_1302101
crossref_primary_10_1097_QAD_0000000000002044
crossref_primary_10_1128_JVI_80_6_3122_3125_2006
crossref_primary_10_1128_JVI_02073_08
crossref_primary_10_1097_QAI_0000000000001458
crossref_primary_10_1111_j_1468_1293_2012_01019_x
crossref_primary_10_1128_JVI_00465_07
crossref_primary_10_1371_journal_pone_0058927
crossref_primary_10_2217_hiv_09_57
crossref_primary_10_1016_j_meegid_2016_03_037
crossref_primary_10_4049_jimmunol_0803928
crossref_primary_10_1111_j_1399_0039_2011_01768_x
crossref_primary_10_1534_genetics_106_057034
crossref_primary_10_1128_JVI_00921_09
crossref_primary_10_1073_pnas_2008615117
crossref_primary_10_1016_j_heliyon_2024_e33143
crossref_primary_10_1073_pnas_1812548116
crossref_primary_10_1155_2011_549023
crossref_primary_10_3892_mmr_2015_3659
crossref_primary_10_1038_srep10879
crossref_primary_10_3389_fimmu_2018_02361
crossref_primary_10_1089_aid_2006_0131
crossref_primary_10_1128_JVI_79_16_10218_10225_2005
crossref_primary_10_4049_jimmunol_1003711
crossref_primary_10_1016_j_meegid_2009_03_007
crossref_primary_10_3389_fimmu_2015_00546
crossref_primary_10_3390_v14020198
crossref_primary_10_1128_JVI_00539_12
crossref_primary_10_3389_fimmu_2015_00665
crossref_primary_10_1097_QAD_0b013e32833a2b5b
crossref_primary_10_1097_01_COH_0000221599_87529_a4
crossref_primary_10_1128_JVI_06150_11
crossref_primary_10_1007_s00251_023_01293_w
crossref_primary_10_1371_journal_pmed_1001900
crossref_primary_10_3390_math8010117
crossref_primary_10_1016_j_humimm_2016_06_013
crossref_primary_10_1146_annurev_med_062909_130018
crossref_primary_10_1086_524143
crossref_primary_10_1016_j_molimm_2014_05_016
crossref_primary_10_1097_QAI_0000000000000901
crossref_primary_10_1111_tan_14256
crossref_primary_10_3389_fimmu_2017_01496
crossref_primary_10_1182_blood_2005_01_0243
crossref_primary_10_1371_journal_pone_0006965
crossref_primary_10_2217_hiv_10_26
crossref_primary_10_1002_eji_201040339
crossref_primary_10_1038_nature08997
crossref_primary_10_1371_journal_pone_0024254
crossref_primary_10_4049_jimmunol_1403074
crossref_primary_10_1111_j_1365_2567_2009_03201_x
crossref_primary_10_1371_journal_pone_0130420
crossref_primary_10_1097_QAI_0000000000002077
crossref_primary_10_1128_JVI_00819_16
crossref_primary_10_1038_s41598_018_23849_7
crossref_primary_10_1128_JVI_02131_12
crossref_primary_10_1371_journal_pone_0176418
crossref_primary_10_1016_j_ijid_2022_12_016
crossref_primary_10_1016_j_coi_2006_05_012
crossref_primary_10_1128_JVI_00912_06
crossref_primary_10_1371_journal_ppat_1010965
crossref_primary_10_1016_j_coi_2006_05_015
crossref_primary_10_1146_annurev_ecolsys_38_091206_095722
crossref_primary_10_1084_jem_20052116
crossref_primary_10_1002_rmv_577
crossref_primary_10_1007_s00251_012_0645_x
crossref_primary_10_1111_j_1365_2796_2008_02045_x
crossref_primary_10_1126_science_1152622
crossref_primary_10_1128_JVI_05201_11
crossref_primary_10_1038_nature05115
crossref_primary_10_1016_j_vaccine_2011_07_132
crossref_primary_10_1038_s41559_018_0509_3
crossref_primary_10_1371_journal_pcbi_0020071
crossref_primary_10_1371_journal_ppat_1000917
crossref_primary_10_4236_oji_2025_151001
crossref_primary_10_1097_QAD_0b013e32832d9267
crossref_primary_10_1128_JVI_01499_21
crossref_primary_10_1016_j_vaccine_2009_07_039
crossref_primary_10_1071_SH04057
crossref_primary_10_1038_s41467_022_33267_z
crossref_primary_10_1128_JVI_00689_12
crossref_primary_10_3389_fimmu_2017_01591
crossref_primary_10_1097_01_aids_0000218560_67155_1c
crossref_primary_10_1097_QAD_0b013e328330b489
crossref_primary_10_1016_j_molimm_2012_10_015
crossref_primary_10_1016_j_humimm_2013_08_287
crossref_primary_10_1038_srep42470
crossref_primary_10_1111_iji_12490
crossref_primary_10_1128_JVI_00821_08
crossref_primary_10_1128_JVI_02050_06
crossref_primary_10_1097_COH_0b013e3282f9ae8b
crossref_primary_10_1371_journal_pgen_1002514
crossref_primary_10_1128_JVI_01596_09
crossref_primary_10_20538_1682_0363_2019_1_119_130
crossref_primary_10_4049_jimmunol_1700502
crossref_primary_10_1002_eji_200939451
crossref_primary_10_1097_BOR_0b013e328362018f
crossref_primary_10_1097_QAD_0b013e32833e5009
crossref_primary_10_1371_journal_pcbi_1000225
crossref_primary_10_1084_jem_20041455
crossref_primary_10_1371_journal_pcbi_1002525
crossref_primary_10_1371_journal_ppat_1005247
crossref_primary_10_3390_v10120677
crossref_primary_10_1097_QAD_0b013e328353bcaf
crossref_primary_10_1371_journal_pbio_1002144
crossref_primary_10_4049_jimmunol_175_4_2459
crossref_primary_10_1073_pnas_0811271106
crossref_primary_10_1016_j_humimm_2011_05_003
crossref_primary_10_1016_j_humgen_2024_201324
crossref_primary_10_1128_JVI_01958_08
crossref_primary_10_3390_math10010096
crossref_primary_10_1007_s00251_017_0974_x
crossref_primary_10_1086_529528
crossref_primary_10_1016_j_vaccine_2014_05_021
crossref_primary_10_1002_hep_22242
crossref_primary_10_1038_ni1206_1281
crossref_primary_10_3109_00365548_2015_1007474
crossref_primary_10_1186_s12979_022_00310_y
crossref_primary_10_1111_tan_13085
crossref_primary_10_1016_j_immuni_2014_12_011
crossref_primary_10_1097_QAD_0b013e32834981b3
crossref_primary_10_1038_s41431_022_01070_5
crossref_primary_10_1111_j_1365_3156_2005_01441_x
crossref_primary_10_1084_jem_20072457
crossref_primary_10_1186_s12977_018_0390_9
crossref_primary_10_1084_jem_20071261
crossref_primary_10_1128_JVI_02329_09
crossref_primary_10_1128_spectrum_01613_23
crossref_primary_10_1517_14712590802571928
crossref_primary_10_1172_JCI98463
crossref_primary_10_1128_JVI_01004_14
crossref_primary_10_1097_COH_0b013e3282f5122a
crossref_primary_10_1002_hep_23101
crossref_primary_10_1097_QAD_0b013e32832c492a
crossref_primary_10_1128_JVI_01236_09
crossref_primary_10_1128_JVI_00968_06
crossref_primary_10_3389_fimmu_2019_00428
crossref_primary_10_1186_1476_9433_5_1
crossref_primary_10_1038_nature07352
crossref_primary_10_1371_journal_ppat_1003041
crossref_primary_10_1097_MD_0000000000003734
crossref_primary_10_1128_JVI_00306_09
crossref_primary_10_1371_journal_pone_0000591
crossref_primary_10_1073_pnas_0707570104
crossref_primary_10_3389_fimmu_2022_886562
crossref_primary_10_1038_news_2010_582
crossref_primary_10_1073_pnas_1413339111
crossref_primary_10_1038_ni_3147
crossref_primary_10_1111_j_1348_0421_2010_00206_x
crossref_primary_10_1093_infdis_jiz589
crossref_primary_10_3389_fimmu_2018_02539
crossref_primary_10_1203_PDR_0b013e31818a07b1
crossref_primary_10_1038_nri2357
crossref_primary_10_1128_JVI_02025_19
crossref_primary_10_1016_j_immuni_2016_09_015
crossref_primary_10_1371_journal_pone_0067016
crossref_primary_10_1089_aid_2008_0208
crossref_primary_10_1371_journal_pcbi_1010355
crossref_primary_10_4049_jimmunol_181_4_2626
crossref_primary_10_1016_j_molimm_2015_07_007
crossref_primary_10_3389_fimmu_2018_01561
crossref_primary_10_1007_s00251_009_0399_2
crossref_primary_10_1371_journal_pone_0023469
crossref_primary_10_1089_aid_2006_0114
crossref_primary_10_1371_journal_pone_0000225
crossref_primary_10_1128_JVI_01120_09
crossref_primary_10_1371_journal_pcbi_0020024
crossref_primary_10_1128_JVI_02014_05
crossref_primary_10_1016_j_ebiom_2021_103258
crossref_primary_10_1186_s12967_014_0217_y
crossref_primary_10_25259_IJDVL_654_19
crossref_primary_10_1038_ni1281
crossref_primary_10_1093_infdis_jiae448
crossref_primary_10_1186_s12977_015_0179_z
crossref_primary_10_1128_JVI_02119_05
crossref_primary_10_1016_j_celrep_2014_03_031
crossref_primary_10_1016_j_vaccine_2008_03_100
crossref_primary_10_1051_mmnp_20127507
crossref_primary_10_1089_aid_2022_0082
crossref_primary_10_1186_1742_4690_10_139
crossref_primary_10_1186_s12977_022_00591_7
crossref_primary_10_1084_jem_20080569
crossref_primary_10_1128_JVI_00800_08
crossref_primary_10_1016_j_celrep_2019_12_087
crossref_primary_10_1186_s13059_017_1385_x
crossref_primary_10_1128_JVI_07077_11
crossref_primary_10_1016_j_vaccine_2007_12_004
crossref_primary_10_4049_jimmunol_1100691
crossref_primary_10_1128_jvi_00811_22
crossref_primary_10_1371_journal_ppat_1002049
crossref_primary_10_1097_QAD_0b013e32810c8bbc
crossref_primary_10_1007_s00251_015_0848_z
crossref_primary_10_1371_journal_ppat_1001196
crossref_primary_10_1128_JVI_00719_19
crossref_primary_10_1155_2014_321974
crossref_primary_10_1111_jvh_13011
crossref_primary_10_1042_BST20220244
crossref_primary_10_1016_j_micinf_2011_03_009
crossref_primary_10_1128_JVI_02477_16
crossref_primary_10_1007_s10709_009_9354_2
crossref_primary_10_1186_1742_4690_5_68
crossref_primary_10_3389_fimmu_2018_01855
crossref_primary_10_1074_jbc_M113_468975
crossref_primary_10_1097_QAD_0000000000000969
crossref_primary_10_1128_JVI_02455_07
crossref_primary_10_1097_QAD_0000000000000728
crossref_primary_10_1128_JVI_00147_14
crossref_primary_10_1097_01_COH_0000232347_15909_22
crossref_primary_10_1128_JVI_07020_11
crossref_primary_10_1146_annurev_immunol_031210_101332
crossref_primary_10_1371_journal_ppat_1006638
crossref_primary_10_1093_ilar_ilt043
crossref_primary_10_1128_JVI_00171_10
crossref_primary_10_1128_JVI_00811_18
crossref_primary_10_1128_JVI_01084_10
crossref_primary_10_1007_s00251_010_0493_5
crossref_primary_10_1128_JVI_01128_17
crossref_primary_10_1016_j_ebiom_2018_09_022
crossref_primary_10_2119_molmed_2016_00031
crossref_primary_10_1371_journal_pone_0001424
crossref_primary_10_1371_journal_ppat_1005661
crossref_primary_10_2217_17469600_2_4_351
crossref_primary_10_1517_14712598_2014_885946
crossref_primary_10_1159_000369209
crossref_primary_10_1002_eji_201040841
crossref_primary_10_1016_j_heliyon_2025_e41836
crossref_primary_10_1128_JVI_79_17_11247_11258_2005
crossref_primary_10_1097_QAD_0b013e32834d3c4f
crossref_primary_10_1126_science_1232685
crossref_primary_10_1093_infdis_jis198
crossref_primary_10_1097_QAI_0b013e3181fe946e
crossref_primary_10_1182_bloodadvances_2022007005
crossref_primary_10_1128_JVI_01966_10
crossref_primary_10_1097_COH_0b013e3282fbaa92
crossref_primary_10_1186_1742_4690_6_72
crossref_primary_10_1097_QAD_0000000000002800
crossref_primary_10_1128_JVI_00022_07
crossref_primary_10_3389_fimmu_2020_00070
crossref_primary_10_4049_jimmunol_1400854
crossref_primary_10_1038_sj_gene_6364368
crossref_primary_10_1371_journal_pone_0034134
crossref_primary_10_1016_j_humimm_2012_04_021
crossref_primary_10_1128_JVI_01151_20
crossref_primary_10_1128_JVI_01381_12
crossref_primary_10_1089_vim_2005_18_500
crossref_primary_10_2217_17460794_1_1_55
crossref_primary_10_1007_s13312_018_1248_x
crossref_primary_10_1097_01_aids_0000247589_77061_f7
crossref_primary_10_1128_JVI_01061_08
crossref_primary_10_1126_scitranslmed_aag1048
crossref_primary_10_1038_ni1241
crossref_primary_10_1097_QAD_0b013e3283021a8c
crossref_primary_10_1371_journal_pcbi_1000981
crossref_primary_10_1371_journal_pone_0011436
crossref_primary_10_1097_01_COH_0000194102_28063_7c
crossref_primary_10_1038_nri_2016_19
crossref_primary_10_1146_annurev_immunol_032712_100001
crossref_primary_10_1146_annurev_immunol_042617_053402
crossref_primary_10_4049_jimmunol_181_1_649
crossref_primary_10_4110_in_2023_23_e17
crossref_primary_10_4049_jimmunol_1202466
crossref_primary_10_1093_infdis_jiw555
crossref_primary_10_1126_science_1131528
crossref_primary_10_1111_j_1600_6143_2011_03863_x
crossref_primary_10_1371_journal_ppat_0020077
crossref_primary_10_1186_s12977_016_0300_y
crossref_primary_10_1371_journal_ppat_0020079
crossref_primary_10_1155_2012_508967
crossref_primary_10_3390_v6083271
crossref_primary_10_1093_hmg_dds226
crossref_primary_10_1186_s12977_015_0149_5
crossref_primary_10_1128_JVI_01162_14
crossref_primary_10_1371_journal_pone_0134037
crossref_primary_10_1038_nm1520
crossref_primary_10_1016_j_ijbiomac_2024_131356
crossref_primary_10_3389_fimmu_2019_01124
crossref_primary_10_3390_v4091711
crossref_primary_10_1097_COH_0b013e328361faf4
crossref_primary_10_1126_science_1195271
crossref_primary_10_1371_journal_pone_0022680
crossref_primary_10_1097_QAD_0000000000002704
crossref_primary_10_1097_01_aids_0000199827_79983_66
crossref_primary_10_1371_journal_ppat_1001033
crossref_primary_10_1128_JVI_01277_07
crossref_primary_10_1128_JVI_01955_15
crossref_primary_10_4049_jimmunol_181_7_5137
crossref_primary_10_1097_QAI_0b013e3181fe9450
crossref_primary_10_1097_QAD_0b013e32835e1616
crossref_primary_10_1128_jvi_00791_24
crossref_primary_10_1016_j_bbrc_2019_10_196
crossref_primary_10_4049_jimmunol_1101970
crossref_primary_10_1371_journal_ppat_1010090
crossref_primary_10_1016_j_meegid_2012_04_011
crossref_primary_10_3390_jcm11071855
crossref_primary_10_1186_1742_4690_4_62
crossref_primary_10_1371_journal_pone_0023515
crossref_primary_10_4049_jimmunol_176_8_4699
crossref_primary_10_1128_JVI_00320_10
crossref_primary_10_3390_vaccines6020018
crossref_primary_10_1128_JVI_06682_11
crossref_primary_10_1007_s00430_019_00585_x
crossref_primary_10_1128_JVI_01998_12
crossref_primary_10_1007_s00705_015_2480_5
crossref_primary_10_1093_cid_cis188
crossref_primary_10_1093_cid_civ219
crossref_primary_10_1097_01_COH_0000221596_41788_52
crossref_primary_10_1007_s00251_011_0552_6
crossref_primary_10_3389_fimmu_2019_00177
crossref_primary_10_1007_s00251_009_0369_8
crossref_primary_10_1182_blood_2011_11_395384
crossref_primary_10_4049_jimmunol_2001405
crossref_primary_10_1016_j_immuni_2012_09_005
crossref_primary_10_1016_j_micinf_2010_10_006
crossref_primary_10_1016_j_virol_2014_08_009
crossref_primary_10_1111_tan_12051
crossref_primary_10_1371_journal_pone_0019018
crossref_primary_10_1086_526786
crossref_primary_10_1371_journal_pone_0001954
crossref_primary_10_1371_journal_pone_0018164
crossref_primary_10_1111_imm_12344
crossref_primary_10_1128_JVI_00569_12
crossref_primary_10_1053_j_gastro_2019_02_003
crossref_primary_10_1089_aid_2006_0080
crossref_primary_10_1128_JVI_00895_07
crossref_primary_10_1016_j_it_2018_07_004
crossref_primary_10_1073_pnas_1718659115
crossref_primary_10_1016_j_jid_2020_12_037
crossref_primary_10_1002_jmv_20848
crossref_primary_10_1097_QAI_0b013e318059beaa
crossref_primary_10_1097_QAD_0000000000002976
crossref_primary_10_1007_s00251_017_1006_6
crossref_primary_10_1371_journal_ppat_1000033
crossref_primary_10_1371_journal_ppat_1003423
crossref_primary_10_3389_fimmu_2021_634832
crossref_primary_10_1016_j_meegid_2015_11_007
crossref_primary_10_1016_j_humimm_2021_01_008
crossref_primary_10_3389_fgene_2021_720213
crossref_primary_10_7554_eLife_34961
crossref_primary_10_1111_imr_12071
crossref_primary_10_7554_eLife_54558
crossref_primary_10_1128_JVI_02017_08
crossref_primary_10_1099_vir_0_022772_0
crossref_primary_10_1182_blood_2012_12_472787
crossref_primary_10_1128_JVI_02428_14
crossref_primary_10_1146_annurev_genom_7_080505_115726
crossref_primary_10_1038_s41409_023_02183_1
crossref_primary_10_1016_j_virol_2012_08_033
crossref_primary_10_1128_JVI_02543_10
crossref_primary_10_1186_1742_4690_9_39
crossref_primary_10_1128_JVI_00276_16
crossref_primary_10_1128_JVI_02520_10
crossref_primary_10_1093_infdis_jiq143
crossref_primary_10_1097_QAD_0000000000000206
crossref_primary_10_1086_520588
crossref_primary_10_1097_QAD_0000000000002868
crossref_primary_10_1097_QAD_0000000000000322
crossref_primary_10_1016_j_humimm_2019_12_003
crossref_primary_10_1371_journal_pcbi_0040015
crossref_primary_10_1128_JVI_00460_11
crossref_primary_10_1084_jem_20201908
crossref_primary_10_1186_s12865_016_0166_8
crossref_primary_10_4049_jimmunol_182_3_1526
crossref_primary_10_1016_j_imlet_2013_09_002
crossref_primary_10_1371_journal_pone_0286507
crossref_primary_10_3390_vaccines11051000
crossref_primary_10_1073_pnas_1204199109
crossref_primary_10_1371_journal_ppat_0030127
crossref_primary_10_1097_QAD_0000000000000574
crossref_primary_10_1128_JVI_01580_06
crossref_primary_10_4049_jimmunol_1004234
crossref_primary_10_4049_jimmunol_1302253
crossref_primary_10_1038_gene_2014_14
crossref_primary_10_4049_jimmunol_1004231
crossref_primary_10_1084_jem_20162123
crossref_primary_10_1186_1742_4690_7_92
crossref_primary_10_1371_journal_pone_0017043
crossref_primary_10_4049_jimmunol_177_7_4699
crossref_primary_10_1086_529387
crossref_primary_10_1128_JVI_01545_08
crossref_primary_10_1002_asia_201100306
crossref_primary_10_1016_j_vaccine_2008_01_012
crossref_primary_10_3748_wjg_v12_i30_4788
crossref_primary_10_4049_jimmunol_176_7_4094
crossref_primary_10_1038_nm1461
crossref_primary_10_1371_journal_ppat_0030045
crossref_primary_10_1111_j_1399_0039_2009_01337_x
crossref_primary_10_1097_QAD_0b013e3282f42412
crossref_primary_10_3390_v14061270
crossref_primary_10_1007_s00251_007_0233_7
crossref_primary_10_2217_pgs_09_121
crossref_primary_10_1371_journal_ppat_1000242
crossref_primary_10_1371_journal_ppat_1000365
crossref_primary_10_1016_j_jim_2009_11_002
crossref_primary_10_1016_j_jhep_2013_08_009
crossref_primary_10_1128_JVI_00580_08
crossref_primary_10_1016_j_bjid_2019_04_009
crossref_primary_10_1128_JVI_03297_12
crossref_primary_10_1103_PhysRevE_108_044407
crossref_primary_10_4049_jimmunol_1101726
crossref_primary_10_1016_j_coi_2005_07_012
crossref_primary_10_1038_s41576_020_00305_9
crossref_primary_10_1016_j_vaccine_2017_08_070
crossref_primary_10_3389_fimmu_2017_00832
crossref_primary_10_1016_j_autrev_2008_03_013
crossref_primary_10_1016_j_virol_2010_05_026
crossref_primary_10_1128_JVI_02171_12
crossref_primary_10_1073_pnas_1009136107
crossref_primary_10_1128_JVI_01636_06
crossref_primary_10_1371_journal_pone_0026096
crossref_primary_10_1111_imcb_12698
crossref_primary_10_1128_JVI_00730_09
crossref_primary_10_1128_JVI_01882_08
crossref_primary_10_1098_rstb_2014_0290
crossref_primary_10_1097_QAD_0b013e3282f88d1b
crossref_primary_10_1371_journal_ppat_1004954
crossref_primary_10_1590_1678_4685_gmb_2023_0198
crossref_primary_10_2217_17584310_3_1_79
crossref_primary_10_1097_QAD_0000000000001202
crossref_primary_10_1371_journal_pone_0010751
crossref_primary_10_1097_QAD_0b013e328182df03
crossref_primary_10_1016_S0140_6736_07_61051_4
crossref_primary_10_1097_QAI_0b013e31816fdc4a
crossref_primary_10_1371_journal_pone_0136417
crossref_primary_10_1126_science_aav5095
crossref_primary_10_1128_JVI_01543_07
crossref_primary_10_1111_j_1399_0039_2005_00527_x
crossref_primary_10_1016_j_jmgm_2017_07_033
crossref_primary_10_1002_hep_21702
crossref_primary_10_1089_aid_2010_0227
crossref_primary_10_1097_QAI_0b013e3181cf30ba
crossref_primary_10_4049_jimmunol_2001145
crossref_primary_10_1016_j_bbrc_2022_03_108
crossref_primary_10_1093_infdis_jit581
crossref_primary_10_1016_j_immuni_2007_08_010
crossref_primary_10_1097_COH_0000000000000918
crossref_primary_10_1097_INF_0b013e3181e5a0fe
crossref_primary_10_1016_j_omtm_2019_07_008
crossref_primary_10_1128_JVI_02032_14
crossref_primary_10_1097_QAD_0b013e328302f39f
crossref_primary_10_1371_journal_ppat_1008177
crossref_primary_10_1080_2162402X_2021_1986943
crossref_primary_10_1053_j_gastro_2011_02_060
crossref_primary_10_1016_j_cub_2005_04_050
crossref_primary_10_1371_journal_pone_0269390
crossref_primary_10_1371_journal_pgen_1004196
crossref_primary_10_1097_COH_0000000000000807
crossref_primary_10_1128_JVI_02636_06
crossref_primary_10_1097_QAD_0000000000002559
crossref_primary_10_4049_jimmunol_181_9_6361
crossref_primary_10_1093_infdis_jis379
crossref_primary_10_1099_vir_0_82357_0
crossref_primary_10_1186_s12879_020_4786_5
crossref_primary_10_1016_j_humimm_2011_01_003
crossref_primary_10_1128_JVI_01962_09
crossref_primary_10_1155_2012_153863
crossref_primary_10_1371_journal_ppat_1008171
crossref_primary_10_1128_JVI_01472_10
crossref_primary_10_3389_fimmu_2018_03032
crossref_primary_10_1089_aid_2013_0067
crossref_primary_10_1128_JVI_80_7_3617_3623_2006
crossref_primary_10_4049_jimmunol_0903745
crossref_primary_10_4049_jimmunol_1601955
crossref_primary_10_1016_j_jviromet_2006_04_009
crossref_primary_10_1016_j_antiviral_2009_08_007
crossref_primary_10_1016_j_vaccine_2015_02_037
crossref_primary_10_1186_1479_5876_9_212
crossref_primary_10_1038_icb_2014_112
crossref_primary_10_1093_cid_cir811
crossref_primary_10_1089_vim_2009_0084
crossref_primary_10_1186_1742_4690_8_54
crossref_primary_10_1128_JVI_02742_06
crossref_primary_10_1097_QAD_0b013e32836146cd
crossref_primary_10_1128_JVI_01847_06
crossref_primary_10_1371_journal_pbio_1001523
crossref_primary_10_4049_jimmunol_1002236
crossref_primary_10_1128_CVI_00169_07
crossref_primary_10_1128_JVI_02031_09
crossref_primary_10_3390_microorganisms12010155
crossref_primary_10_1186_1479_5876_9_208
crossref_primary_10_1371_journal_pone_0005013
crossref_primary_10_1089_aid_2013_0197
crossref_primary_10_1098_rspb_2013_0696
crossref_primary_10_1016_j_yamp_2020_07_016
crossref_primary_10_1016_j_compbiolchem_2019_107195
crossref_primary_10_1084_jem_20081984
crossref_primary_10_1128_JVI_80_10_5074_5077_2006
crossref_primary_10_1016_j_str_2024_04_015
crossref_primary_10_5339_gcsp_2014_60
crossref_primary_10_1128_JVI_06728_11
crossref_primary_10_1186_1742_4690_10_53
crossref_primary_10_1097_QAD_0000000000002213
crossref_primary_10_1126_science_1110009
crossref_primary_10_3389_fimmu_2022_769900
crossref_primary_10_1371_journal_pone_0073117
crossref_primary_10_1128_JVI_00544_17
crossref_primary_10_1016_j_molimm_2006_06_003
crossref_primary_10_1128_JVI_00286_10
Cites_doi 10.1038/357326a0
10.1038/nri1417
10.1016/S1286-4579(00)01287-9
10.1034/j.1399-0039.2002.600301.x
10.1002/eji.1830070816
10.1126/science.272.5258.67
10.1056/NEJM200105313442203
10.1073/pnas.91.13.5893
10.1038/nm992
10.1126/science.1069660
10.1038/nm893
10.1097/00042560-200204150-00009
10.1128/JVI.77.3.2081-2092.2003
10.1038/ng934
10.1056/NEJM199908053410602
10.1038/35103577
10.1128/JVI.77.22.12083-12087.2003
10.1126/science.272.5265.1167
10.1038/35073658
10.1126/science.283.5408.1748
10.1038/nm0496-405
10.1073/pnas.071548198
10.1073/pnas.050567397
10.1016/S1471-4914(01)02131-1
10.1038/357329a0
10.1097/00002030-200405210-00009
ContentType Journal Article
Copyright Macmillan Magazines Ltd. 2005
2005 INIST-CNRS
COPYRIGHT 2004 Nature Publishing Group
Copyright Macmillan Journals Ltd. Dec 9, 2004
Copyright_xml – notice: Macmillan Magazines Ltd. 2005
– notice: 2005 INIST-CNRS
– notice: COPYRIGHT 2004 Nature Publishing Group
– notice: Copyright Macmillan Journals Ltd. Dec 9, 2004
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
ATWCN
3V.
7QG
7QL
7QP
7QR
7RV
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7X2
7X7
7XB
88A
88E
88G
88I
8AF
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
8G5
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BEC
BENPR
BGLVJ
BHPHI
BKSAR
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M2M
M2O
M2P
M7N
M7P
M7S
MBDVC
NAPCQ
P5Z
P62
P64
PATMY
PCBAR
PDBOC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
PTHSS
PYCSY
Q9U
R05
RC3
S0X
SOI
7X8
7SC
7SP
7SR
7TB
7U5
8BQ
F28
JG9
JQ2
KR7
L7M
L~C
L~D
DOI 10.1038/nature03113
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Middle School
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Technology Collection
Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Research Library
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Research Library (Corporate)
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Earth, Atmospheric & Aquatic Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
Engineering Collection
Environmental Science Collection
ProQuest Central Basic
University of Michigan
Genetics Abstracts
SIRS Editorial
Environment Abstracts
MEDLINE - Academic
Computer and Information Systems Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
METADEX
ANTE: Abstracts in New Technology & Engineering
Materials Research Database
ProQuest Computer Science Collection
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
University of Michigan
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
SIRS Editorial
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Research Library
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest Psychology Journals (Alumni)
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
ProQuest Psychology Journals
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
Materials Research Database
Civil Engineering Abstracts
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
Electronics & Communications Abstracts
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
METADEX
Computer and Information Systems Abstracts Professional
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
Advanced Technologies Database with Aerospace
ANTE: Abstracts in New Technology & Engineering
DatabaseTitleList AIDS and Cancer Research Abstracts

MEDLINE - Academic
MEDLINE
Agricultural Science Database
Materials Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Physics
EISSN 1476-4687
EndPage 775
ExternalDocumentID 771766891
A186286327
15592417
16328802
10_1038_nature03113
Genre Journal Article
GeographicLocations Africa, Southern
GeographicLocations_xml – name: Africa, Southern
GroupedDBID ---
--Z
-DZ
-ET
-~X
.-4
.55
.GJ
.HR
00M
08P
0R~
0WA
123
186
1VR
29M
2KS
2XV
39C
3EH
3O-
3V.
4.4
41X
42X
53G
5RE
6TJ
70F
7RV
7X2
7X7
7XC
85S
88A
88E
88I
8AF
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
8G5
8R4
8R5
8WZ
97F
97L
9M8
A6W
A7Z
A8Z
AAEEF
AAHBH
AAHTB
AAIKC
AAJYS
AAKAB
AAMNW
AASDW
AAYEP
AAYOK
AAYZH
ABAWZ
ABDBF
ABDPE
ABDQB
ABEFU
ABFSI
ABIVO
ABJCF
ABJNI
ABLJU
ABNNU
ABOCM
ABPEJ
ABPPZ
ABTAH
ABUWG
ABWJO
ABZEH
ACBEA
ACBWK
ACGFO
ACGFS
ACGOD
ACIWK
ACKOT
ACMJI
ACNCT
ACPRK
ACRPL
ACTDY
ACUHS
ACWUS
ADBBV
ADFRT
ADNMO
ADUKH
ADYSU
AENEX
AEUYN
AFFDN
AFFNX
AFHKK
AFKRA
AFLOW
AFRAH
AFSHS
AGAYW
AGCDD
AGGDT
AGHSJ
AGHTU
AGNAY
AGSOS
AHMBA
AHSBF
AIDAL
AIDUJ
AIYXT
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
APEBS
ARAPS
ARTTT
ASPBG
ATCPS
ATWCN
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BCU
BDKGC
BEC
BENPR
BGLVJ
BHPHI
BIN
BKEYQ
BKKNO
BKOMP
BKSAR
BPHCQ
BVXVI
CCPQU
CJ0
CS3
D1I
D1J
D1K
DB5
DO4
DU5
DWQXO
E.-
E.L
EAD
EAP
EAS
EAZ
EBC
EBD
EBO
EBS
ECC
EE.
EJD
EMB
EMF
EMH
EMK
EMOBN
EPL
EPS
ESE
ESN
ESX
EX3
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HG6
HMCUK
HVGLF
HZ~
I-F
IAO
ICQ
IEA
IEP
IGS
IH2
IHR
INH
INR
IOF
IPY
ISR
ITC
J5H
K6-
KB.
KOO
L-9
L6V
L7B
LK5
LK8
M0K
M0L
M1P
M2M
M2O
M2P
M7P
M7R
M7S
MVM
N4W
N9A
NAPCQ
NEJ
NEPJS
O9-
OBC
OES
OHH
OHT
OMK
OVD
P-O
P2P
P62
PATMY
PCBAR
PDBOC
PKN
PM3
PQQKQ
PROAC
PSQYO
PSYQQ
PTHSS
PYCSY
Q2X
R05
RND
RNS
RNT
RNTTT
RXW
S0X
SC5
SJFOW
SJN
SNYQT
SOJ
SV3
TAE
TAOOD
TEORI
TH9
TN5
TSG
TUS
TWZ
U5U
UIG
UKHRP
UKR
UMD
UQL
USG
VOH
VQA
VVN
WH7
WOW
X7L
X7M
XIH
XKW
XZL
Y6R
YAE
YCJ
YFH
YIF
YIN
YNT
YOC
YQJ
YQT
YR2
YR5
YV5
YXB
YYP
YZZ
Z5M
ZCA
ZCG
ZGI
ZHY
ZKB
ZKG
ZY4
~02
~7V
~88
~8M
~KM
.CO
.XZ
07C
1CY
1OL
1VW
354
41~
4R4
663
79B
AAKAS
AARCD
AAVBQ
AAYXX
ABFSG
ACBNA
ACBTR
ACMFV
ACSTC
ADGHP
ADRHT
ADXHL
ADZCM
AETEA
AEZWR
AFANA
AFBBN
AFHIU
AGQPQ
AHWEU
AIXLP
AJUXI
ALPWD
ARMCB
ATHPR
BCR
BES
BLC
CITATION
FA8
FAC
LGEZI
LOTEE
LSO
NADUK
NFIDA
NXXTH
ODYON
PEA
PHGZM
PHGZT
PV9
QS-
R4F
RHI
SHXYY
SIXXV
SKT
TBHMF
TDRGL
TUD
UBY
UHB
XOL
YJ6
YQI
YXA
YYQ
ZE2
~G0
IQODW
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7QG
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7TG
7TK
7TM
7TO
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
KL.
M7N
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
SOI
7X8
7SC
7SP
7SR
7TB
7U5
8BQ
F28
JG9
JQ2
KR7
L7M
L~C
L~D
ID FETCH-LOGICAL-c684t-964e84a9dca4e289fbdda25d093b26ef04834c3507647ca0faff1fbd283f96033
IEDL.DBID 7X7
ISSN 0028-0836
1476-4687
IngestDate Fri Jul 11 03:06:08 EDT 2025
Fri Jul 11 06:41:59 EDT 2025
Fri Jul 11 06:35:48 EDT 2025
Sat Aug 23 13:16:21 EDT 2025
Fri Jun 13 00:45:40 EDT 2025
Tue Jun 10 15:35:29 EDT 2025
Tue Jun 10 21:28:29 EDT 2025
Fri Jun 27 05:39:44 EDT 2025
Fri Jun 27 05:41:58 EDT 2025
Wed Feb 19 01:39:31 EST 2025
Mon Jul 21 09:15:07 EDT 2025
Thu Apr 24 23:04:16 EDT 2025
Tue Jul 01 04:10:30 EDT 2025
Fri Feb 21 02:37:54 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7018
Keywords Immune response
HIV-1 virus
Retroviridae
Host agent relation
Lentivirus
Virus
Molecular evolution
HLA-A-Locus
Histocompatibility restriction
Human immunodeficiency virus
Class I histocompatibility antigen
HLA-B-Locus
Polymorphism
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c684t-964e84a9dca4e289fbdda25d093b26ef04834c3507647ca0faff1fbd283f96033
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 15592417
PQID 204555591
PQPubID 40569
PageCount 7
ParticipantIDs proquest_miscellaneous_743167943
proquest_miscellaneous_67184536
proquest_miscellaneous_17699214
proquest_journals_204555591
gale_infotracgeneralonefile_A186286327
gale_infotraccpiq_186286327
gale_infotracacademiconefile_A186286327
gale_incontextgauss_ISR_A186286327
gale_incontextgauss_ATWCN_A186286327
pubmed_primary_15592417
pascalfrancis_primary_16328802
crossref_primary_10_1038_nature03113
crossref_citationtrail_10_1038_nature03113
springer_journals_10_1038_nature03113
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-12-09
PublicationDateYYYYMMDD 2004-12-09
PublicationDate_xml – month: 12
  year: 2004
  text: 2004-12-09
  day: 09
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle International weekly journal of science
PublicationTitle Nature (London)
PublicationTitleAbbrev Nature
PublicationTitleAlternate Nature
PublicationYear 2004
Publisher Nature Publishing Group UK
Nature Publishing
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing
– name: Nature Publishing Group
References PM Garcia (BFnature03113_CR16) 1999; 341
AJ McMichael (BFnature03113_CR5) 2001; 410
D Snary (BFnature03113_CR9) 1977; 7
JW Mellors (BFnature03113_CR11) 1996; 272
AJ Leslie (BFnature03113_CR28) 2004; 10
MM Addo (BFnature03113_CR10) 2003; 77
SA Migueles (BFnature03113_CR19) 2000; 97
PO Flores-Villanueva (BFnature03113_CR22) 2001; 98
SGE Marsh (BFnature03113_CR3) 2000
M Badri (BFnature03113_CR12) 2004; 18
M Bunce (BFnature03113_CR27) 2003; 210
CB Moore (BFnature03113_CR14) 2002; 296
DI Watkins (BFnature03113_CR7) 1992; 357
SJ O'Brien (BFnature03113_CR18) 2001; 7
SN McAdam (BFnature03113_CR8) 1994; 91
MP Belich (BFnature03113_CR6) 1992; 357
RA Kaslow (BFnature03113_CR17) 1996; 2
P Parham (BFnature03113_CR2) 1996; 272
E Trachtenberg (BFnature03113_CR21) 2003; 9
ER Cooper (BFnature03113_CR15) 2002; 29
GS Cooke (BFnature03113_CR24) 2001; 2
X Gao (BFnature03113_CR20) 2001; 344
M Carrington (BFnature03113_CR4) 1999; 283
PJ Goulder (BFnature03113_CR13) 2004; 4
CL Thio (BFnature03113_CR26) 2003; 77
KJ Jeffery (BFnature03113_CR1) 2000; 2
M Ramos (BFnature03113_CR25) 2002; 60
MP Martin (BFnature03113_CR23) 2002; 31
References_xml – volume: 357
  start-page: 326
  year: 1992
  ident: BFnature03113_CR6
  publication-title: Nature
  doi: 10.1038/357326a0
– volume: 4
  start-page: 630
  year: 2004
  ident: BFnature03113_CR13
  publication-title: Nature Rev. Immunol.
  doi: 10.1038/nri1417
– volume: 2
  start-page: 1335
  year: 2000
  ident: BFnature03113_CR1
  publication-title: Microbes Infect.
  doi: 10.1016/S1286-4579(00)01287-9
– volume: 60
  start-page: 191
  year: 2002
  ident: BFnature03113_CR25
  publication-title: Tissue Antigens
  doi: 10.1034/j.1399-0039.2002.600301.x
– volume: 7
  start-page: 580
  year: 1977
  ident: BFnature03113_CR9
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830070816
– volume: 272
  start-page: 67
  year: 1996
  ident: BFnature03113_CR2
  publication-title: Science
  doi: 10.1126/science.272.5258.67
– volume: 344
  start-page: 1668
  year: 2001
  ident: BFnature03113_CR20
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200105313442203
– volume: 91
  start-page: 5893
  year: 1994
  ident: BFnature03113_CR8
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.91.13.5893
– volume: 10
  start-page: 282
  year: 2004
  ident: BFnature03113_CR28
  publication-title: Nature Med.
  doi: 10.1038/nm992
– volume: 296
  start-page: 1439
  year: 2002
  ident: BFnature03113_CR14
  publication-title: Science
  doi: 10.1126/science.1069660
– volume: 9
  start-page: 928
  year: 2003
  ident: BFnature03113_CR21
  publication-title: Nature Med.
  doi: 10.1038/nm893
– volume: 29
  start-page: 484
  year: 2002
  ident: BFnature03113_CR15
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/00042560-200204150-00009
– volume: 77
  start-page: 2081
  year: 2003
  ident: BFnature03113_CR10
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.3.2081-2092.2003
– volume: 31
  start-page: 429
  year: 2002
  ident: BFnature03113_CR23
  publication-title: Nature Genet.
  doi: 10.1038/ng934
– volume: 341
  start-page: 394
  year: 1999
  ident: BFnature03113_CR16
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199908053410602
– volume: 2
  start-page: 967
  year: 2001
  ident: BFnature03113_CR24
  publication-title: Nature Rev. Genet.
  doi: 10.1038/35103577
– volume: 77
  start-page: 12083
  year: 2003
  ident: BFnature03113_CR26
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.22.12083-12087.2003
– volume: 272
  start-page: 1167
  year: 1996
  ident: BFnature03113_CR11
  publication-title: Science
  doi: 10.1126/science.272.5265.1167
– volume: 410
  start-page: 980
  year: 2001
  ident: BFnature03113_CR5
  publication-title: Nature
  doi: 10.1038/35073658
– volume: 283
  start-page: 1748
  year: 1999
  ident: BFnature03113_CR4
  publication-title: Science
  doi: 10.1126/science.283.5408.1748
– volume: 210
  start-page: 143
  year: 2003
  ident: BFnature03113_CR27
  publication-title: Methods Mol. Biol.
– volume-title: The HLA Facts Book
  year: 2000
  ident: BFnature03113_CR3
– volume: 2
  start-page: 405
  year: 1996
  ident: BFnature03113_CR17
  publication-title: Nature Med.
  doi: 10.1038/nm0496-405
– volume: 98
  start-page: 5140
  year: 2001
  ident: BFnature03113_CR22
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.071548198
– volume: 97
  start-page: 2709
  year: 2000
  ident: BFnature03113_CR19
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.050567397
– volume: 7
  start-page: 379
  year: 2001
  ident: BFnature03113_CR18
  publication-title: Trends Mol. Med.
  doi: 10.1016/S1471-4914(01)02131-1
– volume: 357
  start-page: 329
  year: 1992
  ident: BFnature03113_CR7
  publication-title: Nature
  doi: 10.1038/357329a0
– volume: 18
  start-page: 1159
  year: 2004
  ident: BFnature03113_CR12
  publication-title: AIDS
  doi: 10.1097/00002030-200405210-00009
SSID ssj0005174
Score 2.3998737
Snippet The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence...
SourceID proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 769
SubjectTerms Africa, Southern
Antigens
Biological and medical sciences
Biological Evolution
CD8-Positive T-Lymphocytes - cytology
CD8-Positive T-Lymphocytes - immunology
Epitopes, T-Lymphocyte - immunology
Evolution
Female
Fundamental and applied biological sciences. Psychology
Gene Frequency
Gene Products, nef - chemistry
Genomics
HIV Infections - immunology
HIV Infections - virology
HIV-1 - genetics
HIV-1 - immunology
HIV-1 - physiology
HLA-A Antigens - genetics
HLA-A Antigens - immunology
HLA-B Antigens - genetics
HLA-B Antigens - immunology
Human immunodeficiency virus 1
Humanities and Social Sciences
Humans
Infant
letter
Leukocytes
Male
Microbiology
multidisciplinary
nef Gene Products, Human Immunodeficiency Virus
Pathogens
Peptides
Polymorphism, Genetic - genetics
Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains
Science
Science (multidisciplinary)
Viral Load
Virology
Title Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
URI https://link.springer.com/article/10.1038/nature03113
https://www.ncbi.nlm.nih.gov/pubmed/15592417
https://www.proquest.com/docview/204555591
https://www.proquest.com/docview/17699214
https://www.proquest.com/docview/67184536
https://www.proquest.com/docview/743167943
Volume 432
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExISQmx8hUGx0PiUrCWx48RPqCsrHYIKlQ36FjmOPU1CSUZa_n7OidMu0NKHPNS_1B93OV_qu98hdJhoISKtIqLyjBLGWUKk8hlRxmdxrkUgpM1G_jLlk3P2aR7NXWxO7cIqO5vYGOq8VPY_8iNLmw4fEbyvrogtGmUPV10FjZto1zKX2YiueB6vIzz-ImF26Xk-TY5a1kxQ6ID2NiRnlu9UsoYlMm1ti03O5z8Hp81-NL6H7jpHEg9bye-hG7rYR7eagE5V76M999DW-I1jln57H80-lG3kC77sapPg0uDJ5yE5hq9wk0Zi46AxuIW4Khc2lAg6USXRv52ONjecfseyyO2ND9D5-ORsNCGuqAJRPGELIjjTCZMiV5JpeNsyWZ7LMMp9QbOQa2Mp5pmi4CZyFivpG2lMACBwQwy87VD6EO0UZaEfIyy40WAu8jyOJWMSPB9tFIe9MGM6Vizz0LtuZVPlGMdt4YufaXPyTZP0mhg8dLgCVy3RxhaYFVFqqSsKGxtzIZd1nQ7Pfoym6TBIbKYtDWMPvdgEO_0264FeO5ApYVxKuowEmJ0lxeohD3pIVV1epddaX_VaL1qxbvqZQU-x1hOFVjCkIfTTaVrqbEmdrjTfQ89XrWAE7MmOLHS5rNMg5kKEAduO4OCDsIhyD-EtiLghRRAMlvhRq-Pr4UHv4OnB-F92Sr8e3gYhPfnvNA7Q7Y4t0xdP0c7i11I_A89ukQ2a5xeuySiw1_HHAdo9Ppl-nf0B4MhOaA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQQSQmx8hcFmoY0vKVo-HCd-QKhsTC3r-jA66JtxHHuahJKMtCD-KP5HzonTLtDytj7Gl_rjznfn-O53CO0mirFIyciVWRq6hJLEFdIjrtQeiTPFfCZMNvLJiPbPyMdJNFlDv9tcGBNW2erEWlFnhTTfyPcNbDr8mP-uvHRN0ShzudpW0Gik4lj9-gknturt4BDYuxcERx_GB33XFhVwJU3I1GWUqIQIlklBFJw2dJplIogyONmnAVXaQKwTGYKbREkshaeF1j4QgRnW4O2b75-g8W-A3fXMhoon8SKi5C_QZ5sO6IXJfoPSCRvIDzsG0JqBO6WogCW6qaWxzNn956K2tn9H99Bd67jiXiNpG2hN5ZvoZh1AKqtNtGGVRIVfWSTr1_fR6WHRRNrgi7YWCi407g977nt4hOu0FRN3jcENxWUxNaFL0IksXPXD7on6hcFnLPLMvPgAnV3Lej9E63mRq8cIM6oVqKcsi2NBiABPS2lJwfamRMWSpA56064slxbh3BTa-Mbrm_Yw4VfY4KDdOXHZAHusIDMs4gYqIzexOOdiVlW8N_5yMOI9PzGZvWEQO-j5MrLBp9MO0UtLpAsYlxQ2AwJmZ0C4OpRbHUpZXlzyK60vOq3nDVuX_c12R7AWE4VWUNwB9NNKGre6q-LzneagnXkrKB1zkyRyVcwq7seUscAnqyko-DwkCqmD8AqKuAZhYASW-FEj44vhQe_gWcL491qhXwxvCZOe_HcaO-hWf3wy5MPB6HgL3W6ROj32FK1Pv8_UM_Aqp-l2vZcx-nrdyuMP4xGImA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIRASQmzAKIPNQhtfUtQmcez4AaGyUrVsVGhs0DfPcexpEko60oL40_jvOCdOu0DL2_oYX-qP-_A5vvsdQnux5jzSKvJUmoQeoST2pOoQT5kOYanmPpc2G_njiA5OyYdxNF5Dv-tcGBtWWdvE0lCnubLfyNsWNh1-3G8bFxXxqdd_O7n0bAEpe9FaV9OoJORQ__oJp7fizbAHrN4Pgv77k4OB5woMeIrGZOpxSnRMJE-VJBpOHiZJUxlEKZzyk4BqY-HWiQrBZaKEKdkx0hgfiGBLNuD522-hYP1vsDDyrYqxMVtEl_wFAO1SAzth3K4QO0GZ_LCxGbot4c5EFsAeU9XVWOb4_nNpW-6F_XvornNicbeSug20prNNdLMMJlXFJtpwBqPALx2q9av76LiXV1E3-KKui4JzgwdHXe8dPMJlCouNwcbgkuJJPrVhTNCJyj39w-lH-cLwC5ZZal98gE6vZb0fovUsz_QjhDk1GkxVmjImCZHgdWmjKOzDCdFMkaSFXtcrK5RDO7dFN76J8tY9jMUVNrTQ3px4UoF8rCCzLBIWNiOzEnguZ0UhuidfD0ai68c2yzcMWAs9W0Y2_HzcIHrhiEwO41LSZUPA7CwgV4Nyu0GpJheX4krr80brecXWZX-z0xCsxUShFYx4AP3UkiacHSvEXOtaaHfeCgbI3irJTOezQviMch74ZDUFBf-HRCFtIbyCgpWADJzAEm9VMr4YHvQOXiaMf78W-sXwljDp8X-nsYtugdkQR8PR4Ta6XYN2dvgTtD79PtNPwcGcJjulKmN0dt224w9ruozO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dominant+influence+of+HLA-B+in+mediating+the+potential+co-evolution+of+HIV+and+hla&rft.jtitle=Nature+%28London%29&rft.au=KIEPIELA%2C+Photini&rft.au=LESLIE%2C+Alasdair+J&rft.au=ZIMBWA%2C+Peter&rft.au=MOORE%2C+Sarah&rft.date=2004-12-09&rft.pub=Nature+Publishing&rft.issn=0028-0836&rft.volume=432&rft.issue=7018&rft.spage=769&rft.epage=774&rft_id=info:doi/10.1038%2Fnature03113&rft.externalDBID=n%2Fa&rft.externalDocID=16328802
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon